WVE News and Press, Wave Life Sciences Ltd. From 03/23/21

Ionis Pharmaceuticals ([[IONS]] -22.5%) has lost almost a fifth after announcing that the partner Roche Holding ([[RHHBY]] -3.3%) has discontinued the dosing in the Phase III GENERATION HD1 study for Tominersen in manifest Huntington's disease (“HD”).An investigational...

Gainers: Dolphin Entertainment (DLPN) +163%.Benitec Biopharma (BNTC) +88%.Liquid Media (YVR) +51%.Takung Art (TKAT) +35%.Evolve Transition Infrastructure (SNMP) +27%.Genius Brands International (GNUS) +17%.The ONE Group Hospitality (STKS) +17%.Glory Star New Media (GSMG) +16%.Funko ...

Gainers: Benitec Biopharma (BNTC) +71%, Hoth Therapeutics (HOTH) +26%, Aerpio Pharmaceuticals (ARPO) +12%, Soliton (SOLY) +11%, China Jo-Jo Drugstores (CJJD) +9%.Losers: Frequency Therapeutics (FREQ) -75%, Windtree Therapeutics (WINT) ...

Frequency Therapeutics (FREQ) -71% after releases new data. from two FX-322 clinical studies; plans to advance single-dose regimen.Anixa Biosciences (ANIX) -23% after raises previously announced bought deal offering of common stock to $22.5M.Windtree Therapeutics (WIN...

Gainers: [[CHMA]] +13.7%. [[RAIL]] +8.3%. [[AMTX]] +7.7%. [[BBGI]] +6.6%. [[NEWT]] +4.9%.Losers: [[WVE]] -15.4%. [[RAVN]] -8.6%. [[DSP]] -7.9%. [[CLSD]] -7.7%. [[PYPL]] -5.7%. For further details see: CHMA, RAIL, WVE and RAVN among after-hours movers

CAMBRIDGE, Mass., March 19, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Exe...

The following slide deck was published by Wave Life Sciences Ltd. in conjunction with their 2020 Q4 earnings call. For further details see: Wave Life Sciences Ltd. 2020 Q4 - Results - Earnings Call Presentation

Wave Life Sciences Ltd. (WVE) Q4 2020 Results Earnings Conference Call March 4, 2021, 08:00 AM ET Company Participants Kate Rausch - Head of Investor Relations Paul Bolno - President and Chief Executive Officer Michael Panzara - Chief Medical Officer, Head of Therapeutics Discovery and Develo...

Wave Life Sciences (WVE): Q4 GAAP EPS of -$0.59 beats by $0.03.Revenue of $9.44M (+293.3% Y/Y) misses by $0.31M.Press Release For further details see: Wave Life Sciences EPS beats by $0.03, misses on revenue

Strong execution in 2020 sets stage for advancing five clinical programs and novel ADAR editing modality in 2021 Data from ongoing PRECISION-HD and OLE clinical trials for Huntington’s disease on track for end of 1Q 2021 Moving towards first patient dosing in thre...